Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma


OĞUZÜLGEN İ. K., Tugay D., TOP M., AYDIN Ö., BAVBEK S., DAMADOĞLU E., ...More

Annual congress of the European-Respiratory-Society (ERS), Milan, Italy, 9 - 13 September 2023, (Summary Text) identifier